Loading...
XNASFTLF
Market cap147mUSD
Jan 16, Last price  
31.99USD
1D
-1.48%
1Q
2.30%
Jan 2017
3,267.37%
IPO
-1.57%
Name

FitLife Brands Inc

Chart & Performance

D1W1MN
XNAS:FTLF chart
P/E
27.78
P/S
2.79
EPS
1.15
Div Yield, %
0.00%
Shrs. gr., 5y
2.30%
Rev. gr., 5y
25.28%
Revenues
53m
+82.97%
09,41411,5302,530,4248,734,5908,148,05312,091,61118,093,20219,684,03019,960,37617,931,46425,313,60117,799,34517,077,00019,497,00021,744,00027,903,00028,803,00052,700,000
Net income
5m
+19.58%
-153,735-649,708-3,961,602-6,625,991-10,782,715-3,178,031326,6522,524,2761,292,4251,673,602-1,165,940368,078-9,761,706509,0002,698,0008,825,0005,410,0004,429,0005,296,000
CFO
4m
+2.18%
-69,654-389,197-1,413,547-4,751,144-1,554,452-1,854,018104,846581,9822,564,7401,506,426-2,455,421-88,416665,781258,0002,261,0005,721,0004,480,0004,130,0004,220,000
Earnings
Mar 31, 2025

Profile

FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. It offers weight loss, general health, and sports nutrition supplements; precision sports nutrition formulations for professional muscular development; weight loss and sports nutrition performance enhancing supplements for fitness enthusiasts; and men's health and weight loss formulations, as well as other diet, health, and sports nutrition supplements and related products; and sports nutritional products, energy and weight loss products, and meal replacements. It markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Metis Nutrition, iSatori, BioGenetic Laboratories, and Energize through franchised stores, as well as through various retail locations, including specialty, mass, and online. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.
URL
https://fitlifebrands.com/
IPO date
Oct 26, 2007
Employees
27
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
52,700
82.97%
28,803
3.23%
Cost of revenue
31,268
16,769
Unusual Expense (Income)
NOPBT
21,432
12,034
NOPBT Margin
40.67%
41.78%
Operating Taxes
1,707
1,393
Tax Rate
7.96%
11.58%
NOPAT
19,725
10,641
Net income
5,296
19.58%
4,429
-18.13%
Dividends
Dividend yield
Proceeds from repurchase of equity
171
(750)
BB yield
-0.18%
0.95%
Debt
Debt current
4,674
54
Long-term debt
15,698
152
Deferred revenue
Other long-term liabilities
Net debt
19,233
(11,224)
Cash flow
Cash from operating activities
4,220
4,130
CAPEX
(106)
Cash from investing activities
(35,993)
Cash from financing activities
20,296
(750)
FCF
16,543
8,734
Balance
Cash
1,139
13,277
Long term investments
(1,847)
Excess cash
9,990
Stockholders' equity
(3,663)
(8,668)
Invested Capital
50,933
29,972
ROIC
48.76%
35.14%
ROCE
43.14%
56.49%
EV
Common stock shares outstanding
4,905
4,975
Price
19.10
19.75%
15.95
-0.31%
Market cap
93,686
18.07%
79,345
1.60%
EV
112,918
68,121
EBITDA
21,526
12,100
EV/EBITDA
5.25
5.63
Interest
1,025
121
Interest/NOPBT
4.78%
1.01%